| 应用 |
A parasympathomimetic or cholinergic agent. |
| 产品介绍 |
Rivastigmine Tartrate是一种胆碱酯酶抑制剂，IC50为5.5 μM，作为副交感神经或胆碱能剂，用于治疗轻度至中度阿尔茨海默病。 |
| 备注 |
Rivastigmine Tartrate, a cholinesterase inhibitor with IC50 of 5.5 μM, ues as a parasympathomimetic or cholinergic agent for the treatment of mild to moderate Alzheimer disease. |
| 生化机理 |
Rivastigmine hydrogen tartrate is a parasympathomimetic or cholinergic agent. Rivastigmine hydrogen tartrate is also a dual ChEI (cholinesterase inhibitor); inhibiting BChE (butyrylcholinesterase) and AChE (acetylcholinesterase). |
| 别名 |
L-酒石酸卡巴拉汀;(S)-N-乙基-N-甲基氨基甲酸-3-[(S)-1-(二甲氨基)乙基]苯酯酒石酸盐;Exelon; Rivastigmine; Rivastigmine Tartrate;N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate;3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate |
